Hilbert Anja
Integrated Research and Treatment Center AdiposityDiseases, Department of Medical Psychology and Medical Sociology, Department of Psychosomatic Medicine and Psychotherapy, University of Leipzig Medical Center, Philipp-Rosenthal-Strasse 27, Leipzig 04103, Germany.
Psychiatr Clin North Am. 2019 Mar;42(1):33-43. doi: 10.1016/j.psc.2018.10.011. Epub 2018 Dec 22.
Binge-eating disorder (BED), first included as a diagnostic entity in the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition, is characterized by recurrent episodes of binge eating without regular compensatory behaviors to prevent weight gain. With a complex multifactorial etiology, BED is the most frequent eating disorder co-occuring with significant psychopathology, mental and physical comorbidity, obesity, and life impairment. Despite its significance, BED is not sufficiently diagnosed or treated. Evidence-based treatments for BED include psychotherapy and structured self-help treatment, with cognitive-behavioral therapy as most well-established approach, and pharmacotherapy with lisdexamfetamine as FDA approved medication with a limitation of use.
暴饮暴食障碍(BED)首次作为一种诊断实体被纳入《精神疾病诊断与统计手册》第五版,其特征是反复出现暴饮暴食发作,且没有为防止体重增加而进行的常规代偿行为。由于病因复杂且涉及多因素,BED是最常与严重精神病理学、身心共病、肥胖和生活功能受损同时出现的饮食失调症。尽管其具有重要性,但BED并未得到充分的诊断和治疗。针对BED的循证治疗包括心理治疗和结构化自助治疗,认知行为疗法是最成熟的方法,药物治疗方面,赖右苯丙胺是美国食品药品监督管理局批准的药物,但使用有一定限制。